XPO1 and triple-negative breast carcinoma: In order to carry out further stages of the experiment, including the effect of uc.63 on the XPO1 gene and the cell cycle, the authors selected the MDA MB 453 line with high uc.63 expression, derived from disseminated, triple-negative breast cancer.